Debt-to-equity of MADRIGAL PHARMACEUTICALS, INC. from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
MADRIGAL PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 30 Jun 2012 to 30 Sep 2025.
  • MADRIGAL PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 58%, a 68% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

MADRIGAL PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 58% +24% +68% 30 Sep 2025
Q2 2025 40% -3% -6.6% 30 Jun 2025
Q1 2025 36% -28% -44% 31 Mar 2025
Q4 2024 33% -90% -73% 31 Dec 2024
Q3 2024 35% -126% -78% 30 Sep 2024
Q2 2024 43% -107% -71% 30 Jun 2024
Q1 2024 64% -78% -55% 31 Mar 2024
Q4 2023 122% +3% +2.2% 31 Dec 2023
Q3 2023 161% +61% +61% 30 Sep 2023
Q2 2023 150% +96% +178% 30 Jun 2023
Q1 2023 142% +109% +329% 31 Mar 2023
Q4 2022 120% +93% +354% 31 Dec 2022
Q3 2022 100% +78% +349% 30 Sep 2022
Q2 2022 54% +35% +182% 30 Jun 2022
Q1 2022 33% +16% +96% 31 Mar 2022
Q4 2021 26% +13% +97% 31 Dec 2021
Q3 2021 22% +12% +117% 30 Sep 2021
Q2 2021 19% +12% +169% 30 Jun 2021
Q1 2021 17% +12% +258% 31 Mar 2021
Q4 2020 13% +10% +265% 31 Dec 2020
Q3 2020 10% +8% +291% 30 Sep 2020
Q2 2020 7% +5% +244% 30 Jun 2020
Q1 2020 5% +3% +186% 31 Mar 2020
Q4 2019 4% +2% +122% 31 Dec 2019
Q3 2019 3% 0% +22% 30 Sep 2019
Q2 2019 2% -1% -39% 30 Jun 2019
Q1 2019 2% -5% -75% 31 Mar 2019
Q4 2018 2% -8% -82% 31 Dec 2018
Q3 2018 2% -12% -84% 30 Sep 2018
Q2 2018 3% -9% -73% 30 Jun 2018
Q1 2018 7% -5% -45% 31 Mar 2018
Q4 2017 9% -4% -28% 31 Dec 2017
Q3 2017 14% -74% -84% 30 Sep 2017
Q2 2017 12% -82% -87% 30 Jun 2017
Q1 2017 12% -85% -88% 31 Mar 2017
Q4 2016 13% -102% -89% 31 Dec 2016
Q3 2016 87% -12% -12% 30 Sep 2016
Q2 2016 94% +4% +4.8% 30 Jun 2016
Q1 2016 97% +4% +4.2% 31 Mar 2016
Q4 2015 115% +10% +9.8% 31 Dec 2015
Q3 2015 99% +29% +41% 30 Sep 2015
Q2 2015 90% -9% -8.9% 30 Jun 2015
Q1 2015 93% -31% -25% 31 Mar 2015
Q4 2014 105% 0% -0.26% 31 Dec 2014
Q3 2014 70% -10% -12% 30 Sep 2014
Q2 2014 99% +34% +53% 30 Jun 2014
Q1 2014 124% +61% +95% 31 Mar 2014
Q4 2013 105% +39% +60% 31 Dec 2013
Q3 2013 80% -24% -23% 30 Sep 2013
Q2 2013 65% -52% -45% 30 Jun 2013
Q1 2013 64% 31 Mar 2013
Q4 2012 66% 31 Dec 2012
Q3 2012 104% 30 Sep 2012
Q2 2012 117% 30 Jun 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.